SCHEMBL2107485

SCHEMBL2107485

CCN1CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14218704 1.00 KMT2A (0.52)
SCHEMBL19750123 1.00 KMT2A (0.52)
SCHEMBL11435054 1.00 KMT2A (0.52)
SCHEMBL327725 1.00 KMT2A (0.52)
SCHEMBL61193 1.00
SCHEMBL24793465 1.00 KMT2A (0.52)
SCHEMBL6506975 1.00
SCHEMBL944 1.00
SCHEMBL5990231 1.00 KMT2A (0.52)
SCHEMBL12402455 1.00 KMT2A (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 242 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240208935-A1 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2024-06-27 US claimed
CN-118125997-A Pterocarpus stilbene paeonol chalcone amide derivative, preparation method and medical application thereof 安徽中医药大学 2024-06-04 CN claimed
CN-117794923-A Benzodioxane compound, and preparation method and application thereof 南京红云生物科技有限公司 2024-03-29 CN claimed
EP-4326712-A1 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES The Regents of The University of California (US) 2024-02-28 EP claimed
CN-116854649-A Gemini quaternary ammonium base type structure directing agent, preparation method thereof, AFX molecular sieve, preparation method thereof and application thereof 华东理工大学 2023-10-10 CN claimed
WO-2022226172-A1 COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-10-27 WO claimed
US-10829466-B2 Stilbene derivative and preparation method thereof BEIJING INSTITUTE OF TECHNOLOGY (CN) 2020-11-10 US claimed
US-20200148662-A1 NOVEL STILBENE DERIVATIVE AND PREPARATION METHOD THEREOF BEIJING INSTITUTE OF TECHNOLOGY (CN) 2020-05-14 US claimed
EP-3041822-B1 COMPOUNDS USEFUL AS IMMUNOMODULATORS BRISTOL MYERS SQUIBB CO (US) 2017-08-09 EP claimed
US-9556185-B2 Organic compounds INTRA-CELLULAR THERAPIES, INC. (US) 2017-01-31 US claimed
EP-1374234-A1 OPTICAL DATA SUPPORT COMPRISING A HEMICYANIN DYE IN THE INFORMATION LAYER AS LIGHT-ABSORBING COMPOUND Bayer Chemicals AG (DE) 2004-01-02 EP claimed
US-20030054291-A1 Optical data storage medium containing a hemicyanine dye as the light-absorbing compound in the information layer LANXESS DEUTSCHLAND GMBH (DE) 2003-03-20 US claimed
WO-2003009847-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEM, INC. (US) 2003-02-06 WO claimed
WO-2002086879-A1 OPTICAL DATA SUPPORT COMPRISING A HEMICYANIN DYE IN THE INFORMATION LAYER AS LIGHT-ABSORBING COMPOUND BAYER AKTIENGESELLSCHAFT (DE) 2002-10-31 WO claimed
US-5367062-A Disubstituted and deoxydisubstituted derivatives of α-d-lyxofuranosides having anti-inflammatory and anti-proliferative activity MEDICARB INC. (US) 1994-11-22 US claimed
US-RE33907-E Anti-spasmodic agents having a heterocyclic ring UNITED PHARMACEUTICALS, INC. (US) 1992-04-28 US claimed
US-4857535-A THIOESTERS UNITED PHARMACEUTICALS (US) 1989-08-15 US claimed
US-4721783-A SMOOTH MUSCLES UNITED PHARMACEUTICALS, INC. (US) 1988-01-26 US claimed
US-4456755-A ANTIBIOTICS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 1984-06-26 US claimed
US-4091115-A ANTIDEPRESSANTS ROUSSEL UCLAF (FR) 1978-05-23 US claimed